1. Home
  2. CADL vs AGNCM Comparison

CADL vs AGNCM Comparison

Compare CADL & AGNCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$10.59

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock

AGNCM

AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock

N/A

Current Price

$25.45

Market Cap

0.0

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
CADL
AGNCM
Founded
1999
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
N/A
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
CADL
AGNCM
Price
$10.59
$25.45
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
1.2M
11.6K
Earning Date
05-14-2026
01-26-2026
Dividend Yield
N/A
8.99%
EPS Growth
58.62
58.06
EPS
N/A
0.37
Revenue
$125,000.00
N/A
Revenue This Year
N/A
$13.57
Revenue Next Year
N/A
$63.17
P/E Ratio
N/A
$68.51
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$23.63
52 Week High
$14.00
$25.36

Technical Indicators

Market Signals
Indicator
CADL
AGNCM
Relative Strength Index (RSI) 42.84 61.35
Support Level $4.91 $25.07
Resistance Level $11.36 N/A
Average True Range (ATR) 0.69 0.12
MACD -0.26 0.00
Stochastic Oscillator 5.54 76.67

Price Performance

Historical Comparison
CADL
AGNCM

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About AGNCM AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock

AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.

Share on Social Networks: